Holen Sie sich die Stockscreener-App
3.04
5.56%
0.16
Handel nachbörslich:
3.14
0.10
+3.29%
Schlusskurs vom Vortag:
$2.88
Offen:
$2.9066
24-Stunden-Volumen:
118.83K
Relative Volume:
1.63
Marktkapitalisierung:
$280.29K
Einnahmen:
$8.77M
Nettoeinkommen (Verlust:
$-19.05M
KGV:
-0.0474
EPS:
-64.1076
Netto-Cashflow:
$-11.60M
1W Leistung:
-3.49%
1M Leistung:
-42.86%
6M Leistung:
-95.66%
1J Leistung:
-98.83%
1-Tages-Spanne:
$2.87
$3.20
1-Wochen-Bereich:
$2.7501
$3.50
52-Wochen-Spanne:
$2.7501
$908.25
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
3.04 | 280.29K | 8.77M | -19.05M | -11.60M | -64.11 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis names Mike McCormick as CEO - MSN
NUWE Q1 2026 Earnings: Massive EPS Miss as Company Reports No RevenueNegative Surprise Momentum - dars.gov.et
Form DEF 14A Nuwellis Inc For: 7 July By Investing.com - Investing.com Nigeria
Nuwellis (NASDAQ: NUWE) seeks warrant share and reverse split votes - Stock Titan
Nuwellis to showcase Aquadex therapy at KidneyB... - Pluang
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 - The Manila Times
Nuwellis takes Aquadex to a pediatric kidney conference in Colorado - Stock Titan
NUWE Q1 2026 Earnings: Significant EPS Miss Highlights Persistent Cost PressuresBuyback Announcement Report - dars.gov.et
NUWENuwellis Inc Short Interest - Finviz
Nuwellis (NASDAQ: NUWE) CEO McCormick files initial insider Form 3 - Stock Titan
NUWE Q1 2026 Earnings: EPS Miss of 104.9% Sends Shares LowerNext Quarter Guidance - dars.gov.et
Nuwellis Inc (FRA:22S1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CHF Solutions, Inc.Special Call Transcript - GuruFocus
Nuwellis Inc (FRA:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Price to cash flow ratio of Nuwellis, Inc. – FWB:22S1 - TradingView
Average basic shares outstanding of Nuwellis, Inc. – FWB:22S1 - TradingView
Net income of Nuwellis, Inc. – FWB:22S1 - TradingView
NUWELL.INC.NEW26 DL-,0001 Financial Statements – FWB:22S1 - TradingView
Nuwellis, Inc. Income Statement – FWB:22S1 - TradingView
Enterprise value to EBITDA forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Price to earnings forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Price to book forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Nuwellis Inc (STU:22S1) DCF Valuation - GuruFocus
Nuwellis Inc (STU:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Nuwellis Inc (STU:22S1) Stock Earnings Transcripts - GuruFocus
Enterprise value to revenue forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Enterprise value to EBIT forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Form PRE 14A Nuwellis Inc For: 26 June - Investing.com UK
Price to sales forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Form PRE 14A Nuwellis Inc For: 26 June By Investing.com - Investing.com Nigeria
Nuwellis marks 5 years supporting pediatric car... - Pluang
Nuwellis (NUWE) asks shareholders to OK 2.4M warrant shares, reverse split option - Stock Titan
Nuwellis Stock Short Interest Falls to 42.32% - Quiver Quantitative
Nuwellis Marks Five Years of Support for PC4 Annual Conference to Advance Pediatric Cardiac Critical Care Education - Quiver Quantitative
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴) - The Manila Times
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴) - GlobeNewswire Inc.
Nuwellis, Inc. Actuals & Estimates (NASDAQ:NUWE) - TradingView
Nuwellis installs systems at Michigan pediatric facility - Investing.com UK
Nuwellis installs systems at Michigan pediatric facility By Investing.com - Investing.com South Africa
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations - The Manila Times
Nuwellis lands first pediatric Aquadex program in Michigan - Stock Titan
Nuwellis’ REVERSE-HF Trial Termination: What It Means for NUWE Investors - TipRanks
Nuwellis CEO outlines growth strategy focusing on pediatric market expansion and improved margins. - Pluang
Nuwellis Reviews 2026 Progress and Outlines Growth Priorities in Shareholder Letter From Incoming CEO Mike McCormick - Moomoo
Nuwellis Reviews 2026 Progress and Outlines Growth Priorities in Shareholder Letter from Incoming CEO Mike McCormick - Quiver Quantitative
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders - The Manila Times
Press Release: Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders - Moomoo
According to documents submitted to the SEC, medical technology company Nuwellis, Inc. announced that its board of directors has approved a 1-for-10 reverse stock split plan, which will officially take effect on June 25, 2026. - Bitget
NuwellisOn June 16, Approves One-For-Thirty-Five Reverse Stock Split Of Common StockSEC Filing - TradingView
Nuwellis, Inc. Announces Reverse Stock Split Approval and Amendment to Certificate of Incorporation - Minichart
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):